Overview

Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence

Status:
Completed
Trial end date:
2018-01-24
Target enrollment:
Participant gender:
Summary
Two groups of patients (73 patients each) undergoing routine caesarean section has recurrent keloid at site of surgical scar. One group will undergo surgical excision of keloid. The other group will have combined surgical excision of keloid and single intralesional dexamethasone injection at edges of wound.All patients were reviewed once per month for 6 months for evidence of recurrence
Phase:
Phase 4
Details
Lead Sponsor:
Kasr El Aini Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate